… Findings from 2D TTE in patients with HFrEF, aside from reduced ejection fraction, might
include atrial and ventricular chamber dilatation or hypertrophy, valvular dysfunction, pericardial …

… Dapagliflozin in patients with heart failure and reduced ejection fraction.  … Prophylactic
implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.  …

… a reduced ejection fraction, vericiguat reduced the … Reduced Ejection Fraction (VICTORIA),
we assessed the efficacy and safety of vericiguat in patients with a reduced ejection fraction …

Heart failure with reduced ejection fraction (HFrEF) develops when cardiac output falls as a
result of cardiac injury. The most well-recognized of the compensatory homeostatic …

… Change in ejection fraction (EF) for patients with preserved and reduced ejection fraction. …
patients with preserved ejection fraction (HFpEF) and heart failure in patients with reserved …

… Within the cohort of newly diagnosed heart failure with reduced ejection fraction (HFrEF)
patients, a subcohort of patients with worsening HF was identified through June 30, 2016. ED = …

… , and neprilysin in reducing the risk of cardiovascular death … with heart failure and a reduced
ejection fraction (HFrEF) for … heart failure with a preserved ejection fraction (HFpEF). This …

… guidelines on heart failure has led to a reduction in recent years in mortality and frequency
of hospitalizations in patients with heart failure and reduced ejection fraction (HFrEF) (2). In …

… In patients with type 2 diabetes, inhibitors of sodium–glucose cotransporter 2 (SGLT2) reduce
… and a reduced ejection fraction, regardless of the presence or absence of type 2 diabetes. …

… reduced ejection fraction (HFmrEF) shares features with both heart failure with reduced
ejection fraction … impairment, and heart failure with preserved ejection fraction (HFpEF), such as …